Dow Jones Top Company Headlines at 1 AM ET: Runway Growth to Expand in Healthcare by Acquiring SWK Holdings | Levi ...

Runway Growth to Expand in Healthcare by Acquiring SWK Holdings

Runway, a lender to sponsor-backed companies, values the transaction at about $229.5 million.

----

Levi Strauss Raises Fiscal-Year Outlook as Turnaround Drives Growth

The jean maker now expects annual revenue to rise about 3% thanks to its focus on its direct-to-consumer business and broader branding efforts.

----

Bankrupt Auto Supplier First Brands Faces Criminal Investigation

The closely held company faces a federal probe after board directors discovered accounting irregularities, sources say.

----

Tesla Self-Driving Technology Breaks Traffic Laws. Can the Feds Stop It?

Safety investigations and the bully pulpit could complicate the automaker's development of automated driving systems, but only if regulators want to.

----

Aritzia's U.S. Expansion Powers Growth Surge in Second Quarter

Revenue in the quarter rose by 41% in the U.S., where the Canadian company is aiming to grow to around 200 stores.

----

PepsiCo Taps Walmart Executive as New CFO

PepsiCo logged higher revenue in its fiscal third quarter, though profit slipped as volumes fell. The company also tapped a Walmart executive to fill its top finance role as PepsiCo aims to turn around its slowing soda and snack sales.

----

Judge Tosses Drake's 'Not Like Us' Defamation Suit

The rapper alleged Universal Music Group promoted Kendrick Lamar's diss track to harm Drake and drive profits.

----

Wendy's Unveils Turnaround to Revitalize Brand

Wendy's has launched a new strategic plan, dubbed "Project Fresh," aimed at revitalizing the brand, reigniting growth, accelerating profitability and enhancing shareholder value.

----

Ferrari Shares Plunge as Long-Term Targets Disappoint

The guidance implies 6% earnings growth a year through the end of the decade, less than what the company suggested in 2022, RBC Capital Markets said.

----

Novo Nordisk to Buy Akero Therapeutics for Up to $5.2 Billion

Akero shareholders will receive $54 per share initially, plus $6 per share contingent on U.S. regulatory approval of its EFX drug by June 30, 2031.

----

Orsted to Slash 2,000 Jobs in Coming Years

A quarter of the workforce will be cut by 2027 as it scales back its global footprint to focus more on offshore wind markets in Europe and select regions in Asia Pacific.

----

Google Plans $5.8 Billion Investment in Belgium

It is the latest large-scale investment from a U.S. tech giant into data center infrastructure in Europe.

----

Banks Warn of Heavier Hit From U.K. Car-Loan Redress

Lloyds Banking Group, Close Brothers and Bank of Ireland cautioned that they would probably need to set aside more money to compensate customers as part of a probe into commissions paid on car loans, sending the shares of the banks lower.

----

HSBC Bids $13.6 Billion for Full Control of Smaller Hong Kong Lender

The U.K.-based bank is advancing its Asia-focused strategy as it continues to streamline its business.


(END) Dow Jones Newswires

October 10, 2025 01:15 ET (05:15 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

Sponsor Center